Editas Medicine (EDIT) Asset Utilization Ratio (2016 - 2025)

Editas Medicine (EDIT) has 10 years of Asset Utilization Ratio data on file, last reported at 0.22 in Q3 2025.

• Quarterly Asset Utilization Ratio rose 29.75% year-over-year to 0.22 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was 0.22 (up 29.75% YoY) and the FY2024 annual result came in at 0.08, down 50.14% from the prior year.
• Asset Utilization Ratio climbed to 0.22 in Q3 2025 per EDIT's latest filing, from 0.16 in the prior quarter.
• Across five years, Asset Utilization Ratio topped out at 0.22 in Q3 2025 and bottomed at 0.03 in Q3 2021.
• The 5-year median for Asset Utilization Ratio is 0.1 (2024), against an average of 0.1.
• The widest annual swing landed in 2021, when Asset Utilization Ratio sank 77.26%; it then surged 323.12% in 2024.
• Tracing EDIT's Asset Utilization Ratio over 5 years: stood at 0.04 in 2021, then grew by 2.94% to 0.04 in 2022, then soared by 312.75% to 0.16 in 2023, then slumped by 37.95% to 0.1 in 2024, then surged by 132.95% to 0.22 in 2025.
• Per Business Quant, the three latest EDIT Asset Utilization Ratio figures stand at 0.22 (Q3 2025), 0.16 (Q2 2025), and 0.12 (Q1 2025).

Peer Comparison